
Nexogen Inc Profile last edited on: 2/14/2019
CAGE: 5F2T6
UEI: YULBN2FLVDL3
Business Identifier: DNA-based diagnostic products for rapid detection of respiratory, cardiovascular and infectious diseases Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
7939 Silverton Avenue Suite 806
San Diego, CA 92126
San Diego, CA 92126
(858) 577-0422 |
contact@nexogentech.com |
www.nexogentech.com |
Location: Single
Congr. District: 52
County: San Diego
Congr. District: 52
County: San Diego
Public Profile
Nexogen, Inc. is developing DNA-based diagnostic products and portable instruments that enable integrated rapid detection of respiratory, cardiovascular and infectious diseases for food, veterinary and medical applications. The firm produces products that will allow fast and integrated sample processing, amplification and detection for the treatment and monitoring of respiratory, cardiovascular and infectious diseases. These products include molecular diagnostic products and platforms, which can be used in point of use, mobile and portable field applications.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2019 | 2 | NIH | $1,201,885 | |
Project Title: A New Rapid DNA Platform for Neonatal Sepsis Diagnostics | ||||
2015 | 1 | NIH | $224,017 | |
Project Title: Universal Modular Sample Preparation Device | ||||
2011 | 1 | Army | $69,478 | |
Project Title: Differentiation of Leishmania in the Sand fly Vector |
Key People / Management
Dalibor Hodko -- Chief Executive Officer
Elizabeth Mather -- Principal Investigator
Elizabeth Mather -- Principal Investigator
Company News
There are no news available.